Vactosertib is a small-molecule compound under investigation for its role as a TGF-beta type I receptor kinase inhibitor, with potential applications in research on fibrotic and neoplastic diseases. It is currently being studied in clinical trials for use in combination with other therapies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vactosertib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Gadoxetate disodium
pharmaceutical raw material
Clarithromycin lactobionate
pharmaceutical raw material
Albendazole-(methyl-d3)
pharmaceutical raw material
Pibrentasvir
pharmaceutical raw material
The international HS code for Vactosertib (CAS 1352608-82-2) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-fluoro-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]aniline
FJCDSQATIJKQKA-UHFFFAOYSA-N
CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4
Sourcing Vactosertib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.